In the current phase II RCT, retatrutide showed remarkable and clinically relevant glycaemic control in a 36-week treatment period
Anyone taking medications for blood sugar, blood pressure, or other conditions should disclose their full medication list during the intake process
And these might also be confounding factors when I think about it, since patients with these Ed prone conditions are more likely than to use GLP-1 agonists
"Mini-Meal" Snacks for When You Need More: On days when I'm too swamped for a proper meal, some of these "snacks" become more like a quick, balanced mini-meal
Reading time: 5 min Author Published on Updated on Weight loss Get expert guidance and a personalized care plan designed around you
However, as of 2023, lixisenatide is no longer available as a standalone agent in the USA